Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Short-term Investments (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Short-term Investments for 13 consecutive years, with $227.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments fell 46.46% year-over-year to $227.2 million, compared with a TTM value of $227.2 million through Sep 2025, down 46.46%, and an annual FY2024 reading of $369.1 million, down 9.77% over the prior year.
  • Short-term Investments was $227.2 million for Q3 2025 at Tandem Diabetes Care, down from $251.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $552.6 million in Q4 2021 and bottomed at $227.2 million in Q3 2025.
  • Average Short-term Investments over 5 years is $413.8 million, with a median of $409.0 million recorded in 2023.
  • The sharpest move saw Short-term Investments surged 358.04% in 2021, then plummeted 46.46% in 2025.
  • Year by year, Short-term Investments stood at $552.6 million in 2021, then decreased by 19.59% to $444.4 million in 2022, then fell by 7.95% to $409.0 million in 2023, then fell by 9.77% to $369.1 million in 2024, then tumbled by 38.45% to $227.2 million in 2025.
  • Business Quant data shows Short-term Investments for TNDM at $227.2 million in Q3 2025, $251.2 million in Q2 2025, and $315.1 million in Q1 2025.